Vontobel Holding Ltd. Biomarin Pharmaceutical Inc Transaction History

Vontobel Holding Ltd.

$27.3 Billion
Q4 2024

A detailed history of Vontobel Holding Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 5,457 shares of BMRN stock, worth $359,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,457

Previous 6,050 9.8%

Holding current value

$359,398

Previous $425,000 15.76%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$61.93 - $70.49 $36,724 - $41,800	-593 Reduced 9.8%	5,457 $358,000
Q3 2024 Oct 15, 2024	BUY	$69.02 - $93.84 $176,208 - $239,573	2,553 Added 73.01%	6,050 $425,000
Q2 2024 Aug 13, 2024	SELL	$74.43 - $92.22 $33,493 - $41,499	-450 Reduced 11.4%	3,497 $287,000
Q1 2024 May 10, 2024	SELL	$83.81 - $99.0 $224,610 - $265,320	-2,680 Reduced 40.44%	3,947 $344,000
Q4 2023 Jun 03, 2024	SELL	$76.22 - $98.51 $76,601 - $99,002	-1,005 Reduced 19.83%	4,063 $391,000
Q4 2023 Jan 29, 2024	SELL	$76.22 - $98.51 $97,256 - $125,698	-1,276 Reduced 16.15%	6,627 $638,000
Q3 2023 Jun 03, 2024	SELL	$85.07 - $94.48 $162,909 - $180,929	-1,915 Reduced 27.42%	5,068 $448,000
Q3 2023 Oct 10, 2023	SELL	$85.07 - $94.48 $162,909 - $180,929	-1,915 Reduced 19.5%	7,903 $699,000
Q2 2023 Jun 03, 2024	BUY	$86.68 - $100.3 $92,314 - $106,819	1,065 Added 18.0%	6,983 $605,000
Q2 2023 Jul 24, 2023	BUY	$86.68 - $100.3 $92,314 - $106,819	1,065 Added 12.17%	9,818 $851,000
Q1 2023 Jun 03, 2024	BUY	$87.74 - $117.27 $172,935 - $231,139	1,971 Added 49.94%	5,918 $575,000
Q1 2023 Apr 12, 2023	BUY	$87.74 - $117.27 $281,996 - $376,905	3,214 Added 58.02%	8,753 $851,000
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $50,419 - $67,676	623 Added 12.67%	5,539 $573,000
Q3 2022 Nov 04, 2022	SELL	$82.16 - $96.94 $128,251 - $151,323	-1,561 Reduced 24.1%	4,916 $418,000
Q2 2022 Jul 27, 2022	SELL	$71.48 - $86.85 $53,895 - $65,484	-754 Reduced 10.43%	6,477 $544,000
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $79,925 - $99,734	-1,076 Reduced 12.95%	7,231 $563,000
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $53,503 - $68,236	746 Added 9.87%	8,307 $739,000
Q3 2021 Oct 29, 2021	SELL	$74.77 - $85.47 $13,383 - $15,299	-179 Reduced 2.31%	7,561 $584,000
Q2 2021 Aug 06, 2021	BUY	$75.51 - $84.79 $81,777 - $91,827	1,083 Added 16.27%	7,740 $646,000
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $94,383 - $114,541	-1,263 Reduced 15.95%	6,657 $503,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $575,071 - $714,384	7,920 New	7,920 $684,000

Others Institutions Holding BMRN

# of Institutions

648

Shares Held

180M

Call Options Held

2.03M

Put Options Held

1.29M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Biomarin Pharmaceutical Inc Transaction History